GRCE smart money

Grace Therapeutics, INC. (GRCE): 4 insider buys in the public filings.

Insider buys, 12 months$479k

Insider buys

FiledWhoRoleAmountPrice
2026-10-26Opaleye Management INC.10% owner$117k$1.77
2026-10-16Opaleye Management INC.10% owner$69k$1.89
2026-10-05Opaleye Management INC.10% owner$79k$2.04
2026-09-10Kohli PrashantChief Executive Officer$214k$2.14
Open the live smart money map